Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.
$86.54 +0.36 (0.42%)
As of 05/23/2022 15:59:59 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.